I will examine the challenges faced by Biopure in sequencing the release of 2 drugs. One ‚Oxyglobin‚ is ready for the Veterinary Market‚ and the other‚ Hemopure‚ whose success could rely on the brand management of the former. I will look at issues related to the success of the company and make the recommendation to launch Oxyglobin now. Currently Biopure creates blood products for two markets‚ human and veterinary. While Oxyglobin is ready to release for the veterinary market‚ Hemopure is 2 years
Premium Blood Blood transfusion
BIOPURE Corporation. 1. Give your best estimate of the sizes of Biopure’s market‚ potential market‚ and what you recommend as the target market in the animal market? Do the same for the human blood market? Who are these people (or animals)? Since the definitions of these different markets can be vague‚ it may be useful to operationalize these concepts in terms of circles on a target which represent the likelihood of being a customer and when they should be targeted by the company. Thus‚ the “target
Free Blood Blood transfusion Surgery
Andrew Walters 3/22/12 Biopure Biopure Corporation specializes in blood substitutes for transfusion patients‚ both in the veterinary market and the human market. However‚ in 1998‚ Biopure faced the monumental decision of whether to begin selling Oxyglobin‚ a blood substitute‚ to the veterinary market or to wait until Hemoglobin‚ a blood substitute for the human market‚ became available for sale. The problem is whether or not the company should launch Oxyglobin before Hemoglobin is FDA-approved
Premium Blood transfusion Blood
Carl Rausch FROM: RE: Biopure Market Analysis DATE: Oct 31‚ 2013 Deciding whether to go into the veterinary blood market now or not is a critical decision to Biopure right now. To maximize the profits and capture the valuable opportunity‚ Biopure is recommended to step into the marketplace and be the first to offer Oxyglobin‚ blood substitute for the animal market. Pioneering the veterinary blood market is expected to generate gross profits of $26.55 miilion to Biopure annually‚ with a breakeven
Premium Blood transfusion Blood
BIOPURE CASE SUMMARY Course: Strategic Marketing Management Name: Firat Sekerli The Problem: Biopure Corporation has two new products that are Oxyglobin and Hemopure. Oxyglobin is the first new blood substitute for the veterinary market and is ready for consumer use. Hemopure is another new blood substitute for the human market and it will take two years to launch the product from now on. Ted Jacobs‚ vice president for Human Clinical
Premium Marketing Blood transfusion Blood
INTRODUCTION In the case of Biopure‚ the issue is to decide whether to launch Oxyglobin and how to launch it without jeopardizing the potential of Hemopure. Oxyglobin is a substitute to animal blood while Hemopure is a substitute to human blood. The CEO need to identify the influence of the launch of Oxyglobin bring to Hemopure. If the company is launching Oxyglobin‚ the CEO need to decide the price‚ identify the target client‚ choose distributing method and consider the production capacity. The
Free Blood Blood transfusion Veterinary medicine
strategies based on LIFE STYLE segmentation‚ almost attracting different niches‚ charging a premium price and offering the desired product in a unique pattern‚ the decision to expand abroad is still a big question mark Solutions required for below Issues/Situations: a). Being a part of strategic management at Amir Adnan‚ what other segmentation techniques will you propose in order to capture the foreign markets successfully as merely lifestyle segmentation is not functional enough for the
Premium Market Design Strategic management
Sep 19 Student Name: Miao Wang Net ID: mxw142330 Case Study 1 Biopure Case Questions: 1. Hemopure: a. Identify relevant market segments and speculate whether the product is valuable to each segment at the suggested prices ($600-$800) As the case said the Biopure in human market‚ sometime the Hemopure could be $600-$800 per unit‚ which is very higher price than the Oxyglobin. This high price product which relevant market segments should be taken this price level ‚ following the attach Exhibit
Free Blood Red blood cell Blood transfusion
Copa Cruises - Welcome Aboard! Copa Cruises is a 40-year old company that offers dining and sightseeing cruises. What started with only one ship at Maryland’s Eastern Shore‚ is now a big business operating at multiple locations with 40 vessels. Copa operates scheduled tours at least twice daily during the peak travel/tourism seasons at each of its locations. The total number of scheduled tours varies based on the number of vessels available at each location. Copa also offers its ships exclusively
Premium Pricing Revenue Price
The Fashion Channel needed to boost segmentation‚ positioning and advertising in order to maintain their current standing. Dana Wheeler was hired to draw on their strengths to help TFC eliminate competitors. TFC realized they need to focus on their target market of women between the ages of 18 to 34 years old. Overview of Recommended Action Dana Wheeler should consider the following these steps in trying to increase ad revenue: 1. She can target segmentation and position towards women between
Premium Target market Cable television Advertising